Literature DB >> 26049057

Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.

Kate Devine1, Sunni L Mumford2, Mae Wu3, Alan H DeCherney3, Micah J Hill4, Anthony Propst5.   

Abstract

OBJECTIVE: To evaluate trends in diminished ovarian reserve (DOR) assignment in the Society for Assisted Reproductive Technology (SART) Clinic Outcomes Reporting System database and to evaluate its accuracy in predicting poor ovarian response (POR) as defined in European Society of Human Reproduction and Embryology's Bologna criteria (2011).
DESIGN: Retrospective cohort study.
SETTING: Not applicable. PATIENT(S): A total of 181,536 fresh, autologous ART cycles reported to SART by U.S. clinics in 2004 and 2011 (earliest and most recent available reporting years). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): DOR assignment was the primary exposure. POR, defined as cycle cancellation for poor response or less than 4 oocytes retrieved after conventional gonadotropin stimulation (>149 IU FSH daily), was the primary outcome. Secondary outcomes were live birth and number of oocytes retrieved. DOR prevalence, power of DOR and FSH (</≥12 mIU/mL) to predict POR, and live birth in POR cycles were also calculated. RESULT(S): DOR prevalence increased from 19% to 26% from 2004 to 2011. Among cycles clinically assigned as DOR, incidence of POR decreased from 32% to 30%, and live birth improved from 15% to 17%. Comparing basal FSH ≥12 versus clinical assignment of DOR, basal FSH had a higher specificity (92.2% vs. 81.6%) and positive predictive value (38.3% vs. 30.9%) for predicting POR. Live birth among POR cycles was 4%. CONCLUSION(S): DOR diagnosis is increasing, and accuracy remains poor, despite the availability of additional diagnostic parameters such as antral follicle count and antimüllerian hormone. POR entailed poor outcomes, but the majority of patients clinically assigned as DOR did not experience POR. Development and use of more accurate predictors of POR are needed to minimize patient distress resulting from overdiagnosis.
Copyright © 2015 American Society for Reproductive Medicine. All rights reserved.

Entities:  

Keywords:  Diminished ovarian reserve; FSH; diagnosis; live birth; poor ovarian response

Mesh:

Substances:

Year:  2015        PMID: 26049057      PMCID: PMC4560955          DOI: 10.1016/j.fertnstert.2015.05.017

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  42 in total

1.  Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Fertil Steril       Date:  2010-06-11       Impact factor: 7.329

2.  Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.

Authors:  David H Barad; Andrea Weghofer; Norbert Gleicher
Journal:  Fertil Steril       Date:  2009-02-12       Impact factor: 7.329

Review 3.  Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.

Authors:  Stamatina Iliodromiti; Richard A Anderson; Scott M Nelson
Journal:  Hum Reprod Update       Date:  2014-12-08       Impact factor: 15.610

4.  A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization.

Authors:  Laura Detti; Daniel B Williams; Jared C Robins; Rose A Maxwell; Michael A Thomas
Journal:  Fertil Steril       Date:  2005-11       Impact factor: 7.329

Review 5.  Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology.

Authors:  Demián Glujovsky; Debbie Blake; Cindy Farquhar; Ariel Bardach
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

6.  Levels and associations among self-esteem, fertility distress, coping, and reaction to potentially being a genetic carrier in women with diminished ovarian reserve.

Authors:  Ceylan Cizmeli; Marci Lobel; Jason Franasiak; Lisa M Pastore
Journal:  Fertil Steril       Date:  2013-03-15       Impact factor: 7.329

7.  Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study.

Authors:  Aygul Demirol; Timur Gurgan
Journal:  Fertil Steril       Date:  2008-11-05       Impact factor: 7.329

8.  Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011.

Authors:  Samantha F Butts; Carter Owen; Monica Mainigi; Suneeta Senapati; David B Seifer; Anuja Dokras
Journal:  Fertil Steril       Date:  2014-07-30       Impact factor: 7.329

Review 9.  The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count.

Authors:  Simone L Broer; Ben Willem J Mol; Dave Hendriks; Frank J M Broekmans
Journal:  Fertil Steril       Date:  2008-03-05       Impact factor: 7.329

10.  Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria.

Authors:  Bei Xu; Zhou Li; Jing Yue; Lei Jin; Yufeng Li; Jihui Ai; Hanwang Zhang; Guijin Zhu
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

View more
  30 in total

1.  Morphological and molecular variations induce mitochondrial dysfunction as a possible underlying mechanism of athletic amenorrhea.

Authors:  Ruo-Hong Xiong; Shi-Lei Wen; Qiang Wang; Hong-Ying Zhou; Shi Feng
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

Review 2.  Treatment Progress in Diminished Ovarian Reserve: Western and Chinese Medicine.

Authors:  Qiao-Li Zhang; Ya-Ling Lei; Yan Deng; Rui-Lin Ma; Xue-Song Ding; Wei Xue; Ai-Jun Sun
Journal:  Chin J Integr Med       Date:  2022-01-11       Impact factor: 1.978

3.  Investigation of the Predictive Factors of Diminished Ovarian Reserve in Women Aged Less Than 40 Years and Undergoing ICSI Cycle.

Authors:  Mohammed M Laqqan; Maged M Yassin
Journal:  Reprod Sci       Date:  2022-08-24       Impact factor: 2.924

4.  Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective in Women with Impending Ovarian Failure and Diminished Ovarian Reserve.

Authors:  Chao-Chin Hsu; Isabel Hsu; Li-Hsuan Lee; Yuan-Shuo Hsueh; Chih-Ying Lin; Hui Hua Chang
Journal:  Biomedicines       Date:  2022-06-03

Review 5.  Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.

Authors:  Lisa M Pastore; Mindy S Christianson; James Stelling; William G Kearns; James H Segars
Journal:  J Assist Reprod Genet       Date:  2017-10-02       Impact factor: 3.412

6.  Maternal and Neonatal Complications in Patients With Diminished Ovarian Reserve in In-Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles.

Authors:  Shuang Han; Yiwei Zhai; Qingqing Guo; Yiming Qin; Peihao Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-29       Impact factor: 5.555

7.  Development of a predictive model for luteal phase oocyte retrieval in poor responders undergoing natural cycle IVF.

Authors:  Mara Simopoulou; Dionysios Galatis; Evangelos Maziotis; Agni Pantou; Polina Giannelou; Sokratis Grigoriadis; Panagiotis Tzonis; Theodora Griva; Athanasios Zikopoulos; Anastasios Philippou; Michael Koutsilieris; Konstantinos Pantos; Konstantinos Sfakianoudis
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

8.  Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.

Authors:  Flavia Magri; Lucia Schena; Valentina Capelli; Margherita Gaiti; Francesca Zerbini; Emanuela Brambilla; Mario Rotondi; Mara De Amici; Arsenio Spinillo; Rossella E Nappi; Luca Chiovato
Journal:  Reprod Biol Endocrinol       Date:  2015-09-21       Impact factor: 5.211

9.  Association of body mass index with serum anti-Müllerian hormone and inhibin B levels among 8323 women attending a reproductive medical center: a cross-sectional study.

Authors:  Yaqi Wang; Li Wu; Zhengyu Yang; Ruijun Xu; Yonggang Duan; Jiajia Lin; Xiuqing Cui; Chuangang Fan; Yun Zhou; Wei Bao; Lei Jin; Yuewei Liu
Journal:  Endocrine       Date:  2021-08-07       Impact factor: 3.633

10.  Human amnion-derived mesenchymal stem cells improved the reproductive function of age-related diminished ovarian reserve in mice through Ampk/FoxO3a signaling pathway.

Authors:  Hanwen Liu; Chunyan Jiang; Boya La; Meng Cao; Song Ning; Jing Zhou; Zhengjie Yan; Chuyu Li; Yugui Cui; Xiang Ma; Meilian Wang; Li Chen; Youjia Yu; Feng Chen; Yuexin Zhang; Huimin Wu; Jiayin Liu; Lianju Qin
Journal:  Stem Cell Res Ther       Date:  2021-06-02       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.